Stockholm, 31 May 2023. Redwood Pharma AB (publ) announces positive results from the company’s clinical study with RP501, a medical... View Article
Stockholm, March 17, 2023. Redwood Pharma AB (publ) announces that the company has now completed recruitment and the last person... View Article
Stockholm, 24 January 2023. Redwood Pharma AB (publ) announces that the company has completed further preparations for the scale-up of... View Article
Stockholm, Sweden, December 15, 2022. Redwood Pharma AB (publ) has entered a partnership with Nextec medical GmbH to act as... View Article
Redwood Pharma will participate in the Aktieportföljen Live in Stockholm. CEO Martin Vidaeus will update the market about its products... View Article
Redwood Pharma will participate in the BioStock Investor Meeting in Stockholm. CEO Martin Vidaeus will update the market about i.e.... View Article
Redwood Pharma will participate at the BioStock Investor Meeting on June 8. The presentation starts at 12:40 pm CET. Follow the event online... View Article
Redwood Pharma’s CEO Martin Vidaeus gave an update of the company, its development programs and focus for 2022. Download the... View Article